By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...
GlobalData on MSN
FDA puts REGENXBIO gene therapy trials on hold after brain tumour
A five-year-old patient dosed with RGX-111 has developed a brain tumour four years after being dosed with the gene therapy.
Tens of thousands of cholesterol medication bottles are being recalled nationwide due to manufacturing issues that could ...
By Kamal Choudhury Jan 30 (Reuters) - Shares of Corcept Therapeutics fell 16% on Friday after a corrected "complete response ...
DOJ accuses Louisiana AG, alleged victim of abortion coercion of trying to "short circuit" FDA's review of mifepristone's ...
The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation of arsenic trioxide, for the treatment of acute promyelocytic leukemia (APL), an aggressive ...
Almost 85,000 bottles of Parodontax Active Gum Health mouthwash have been recalled nationwide. The bottles may have missing ...
Jan 28 (Reuters) - Regenxbio said on Wednesday the U.S. Food and Drug Administration has placed a clinical hold on two of its ...
The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after ...
On Friday, the FDA reported finding bacteria that causes infant botulism in two samples connected to ByHeart infant formula.
The Trump administration seeks to pause a Louisiana abortion pill lawsuit, keeping Biden-era mail-order access rules in place ...
The target action date for orforglipron is now April 10.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results